---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280692859.md"
description: "In Thursday's after-market session, several health care stocks experienced notable movements. Gainers included Vyome Holdings (up 11.3% to $2.45), Tiziana Life Sciences (up 11.19% to $1.39), and Lunai Bioworks (up 10.69% to $0.55). Conversely, Precision Optics Corp saw a decline of 14.5% to $3.6, while Modular Medical dropped 13.8% to $0.15. Other notable losers included Zenas BioPharma (down 9.75% to $20.0) and Eupraxia Pharmaceuticals (down 8.91% to $6.24)."
datetime: "2026-03-26T21:05:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280692859.md)
  - [en](https://longbridge.com/en/news/280692859.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280692859.md)
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **Vyome Holdings** (NASDAQ:HIND) shares rose 11.3% to $2.45 during Thursday's after-market session. The company's market cap stands at $15.9 million.
-   **Tiziana Life Sciences** (NASDAQ:TLSA) stock moved upwards by 11.19% to $1.39. The market value of their outstanding shares is at $171.7 million.
-   **Lunai Bioworks** (NASDAQ:LNAI) stock increased by 10.69% to $0.55. The market value of their outstanding shares is at $9.7 million.
-   **SIGA Technologies** (NASDAQ:SIGA) shares moved upwards by 10.38% to $5.47. The company's market cap stands at $356.4 million.
-   **Alpha Cognition** (NASDAQ:ACOG) stock moved upwards by 10.11% to $5.88. The company's market cap stands at $115.6 million. The company's, Q4 earnings came out today.
-   **Reviva Pharmaceuticals** (NASDAQ:RVPH) stock increased by 6.5% to $0.83. The market value of their outstanding shares is at $10.5 million.

### Losers

-   **Precision Optics Corp** (NASDAQ:POCI) stock declined by 14.5% to $3.6 during Thursday's after-market session. The market value of their outstanding shares is at $34.6 million.
-   **Modular Medical** (NASDAQ:MODD) shares decreased by 13.8% to $0.15. The company's market cap stands at $26.1 million.
-   **Zenas BioPharma** (NASDAQ:ZBIO) stock decreased by 9.75% to $20.0. The company's market cap stands at $1.2 billion.
-   **Eupraxia Pharmaceuticals** (NASDAQ:EPRX) shares declined by 8.91% to $6.24. The company's market cap stands at $435.4 million.
-   **Firefly Neuroscience** (NASDAQ:AIFF) stock decreased by 8.28% to $2.77. The market value of their outstanding shares is at $26.3 million.
-   **Radiopharm Theranostics** (NASDAQ:RADX) shares declined by 7.77% to $3.92. The company's market cap stands at $33.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [TLSA.US](https://longbridge.com/en/quote/TLSA.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [ZBIO.US](https://longbridge.com/en/quote/ZBIO.US.md)
- [EPRX.US](https://longbridge.com/en/quote/EPRX.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [HIND.US](https://longbridge.com/en/quote/HIND.US.md)
- [MODD.US](https://longbridge.com/en/quote/MODD.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [POCI.US](https://longbridge.com/en/quote/POCI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Zenas BioPharma Insider Bought Shares Worth $1,012,800, According to a Recent SEC Filing](https://longbridge.com/en/news/286872009.md)
- [Zenas BioPharma To Present INDIGO Phase 3 Data At EULAR 2026; Wedbush Sees $45 Target](https://longbridge.com/en/news/286916856.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Zenas BioPharma Highlights Strong Q1 Progress and Financing](https://longbridge.com/en/news/286243392.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)